Omnicell Inc
NASDAQ:OMCL
Omnicell Inc
Cash from Financing Activities
Omnicell Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Omnicell Inc
NASDAQ:OMCL
|
Cash from Financing Activities
$23.4m
|
CAGR 3-Years
-63%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
12%
|
|
Veeva Systems Inc
NYSE:VEEV
|
Cash from Financing Activities
-$16.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Cash from Financing Activities
$14m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
Evolent Health Inc
NYSE:EVH
|
Cash from Financing Activities
$281.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Doximity Inc
NYSE:DOCS
|
Cash from Financing Activities
-$74.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
Cash from Financing Activities
-$167.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-47%
|
CAGR 10-Years
N/A
|
See Also
What is Omnicell Inc's Cash from Financing Activities?
Cash from Financing Activities
23.4m
USD
Based on the financial report for Dec 31, 2023, Omnicell Inc's Cash from Financing Activities amounts to 23.4m USD.
What is Omnicell Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
12%
The average annual Cash from Financing Activities growth rates for Omnicell Inc have been -63% over the past three years , and 12% over the past ten years .